Intestinal Lymphangiectasis

Dilatation of the intestinal lymphatic system usually caused by an obstruction in the intestinal wall. It may be congenital or acquired and is characterized by DIARRHEA; HYPOPROTEINEMIA; peripheral and/or abdominal EDEMA; and PROTEIN-LOSING ENTEROPATHIES.

Also Known As:

Networked: 8 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Protein-Losing Enteropathies (Protein-Losing Enteropathy)
2.	Lymphoma (Lymphomas)
3.	Lipidoses

Experts

1.	Navacchia, Daniel: 1 article (03/2015)
2.	Sommaruga, Horacio: 1 article (03/2015)
3.	Santarcángelo, Salomé Catalina: 1 article (03/2015)
4.	Quintana, Carlos: 1 article (03/2015)
5.	Hill, Georgette D: 1 article (06/2012)
6.	Lieuallen, Warren G: 1 article (06/2012)
7.	Boyle, Michael C: 1 article (06/2012)
8.	Painter, J Todd: 1 article (06/2012)
9.	Crabbs, Torrie A: 1 article (06/2012)
10.	Nyska, Abraham: 1 article (06/2012)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Intestinal Lymphangiectasis:

1.	Staphylococcal Protein A (A, Protein)IBA 03/01/2015 - "Congenital intestinal lymphangiectasis (LIP) is a protein-losing enteropathy that appears sporadically in children. " 09/01/2000 - "Waldman disease, also called intestinal lymphangiectasis, is a protein-loosing enteropathy caused by anomalous intestinal lymphatic canals. "
2.	Mebendazole (Vermin)FDA Link 05/01/1980 - "The authors present a patient with intestinal lymphangiectasis discussing the pathophysiology, diagnosis and immunologic treatment instituted which was with mebendazole, sulfazalosopyridine and oral calcium. "
3.	CalciumIBA 05/01/1980 - "The authors present a patient with intestinal lymphangiectasis discussing the pathophysiology, diagnosis and immunologic treatment instituted which was with mebendazole, sulfazalosopyridine and oral calcium. "
4.	Urioste Martinez-Frias syndromeIBA 11/15/2001 - "Persistence of Müllerian derivatives and intestinal lymphangiectasis in two newborn brothers: confirmation of the Urioste syndrome."
5.	indole-3-carbinolIBA 06/01/2012 - "Intestinal lymphangiectasis and lipidosis in rats following subchronic exposure to indole-3-carbinol via oral gavage."

Therapies and Procedures

1.	Parenteral Nutrition 01/01/1969 - "Treatment of protein losing enteropathy due to idiopathic intestinal lymphangiectasis by parenteral nutrition."
2.	Combination Drug Therapy (Combination Chemotherapy) 01/01/1981 - "The simultaneous cure of both the intestinal lymphangiectasia and lymphoma with combination chemotherapy suggests new relationships between these conditions as well as new possibilities for the treatment of acquired forms of intestinal lymphangiectasis associated with overwhelming gastrointestinal protein loss."
3.	Diet Therapy (Therapy, Diet) 09/28/1980 - "[Diet therapy of intestinal lymphangiectasis]."